Fukuda Denshi CoTSE:6960 +1.78%81 EBITDA Margin % is 0.53% as of Dec. 2025, which is 98% below its 10-year median of 22.43. GuruFocus rates TSE:6960 with a GF Score™ of 81/100 and a GF Value™ of 円7,323.71 (Significantly Overvalued). Among 816 Medical Devices & Instruments companies, Fukuda Denshi Co ranks better than 88.24% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Fukuda Denshi Co's EBITDA for the
three
months ended in Dec. 2025 was 円179 Mil. Fukuda Denshi Co's Revenue for the
three
months ended in Dec. 2025 was 円34,050 Mil. Therefore, Fukuda Denshi Co's EBITDA margin for the quarter that ended in Dec. 2025 was 0.53%.
Fukuda Denshi Co (TSE:6960) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Fukuda Denshi Co EBITDA Margin % Related Terms
Fukuda Denshi Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Fukuda Denshi Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6960 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Fukuda Denshi Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fukuda Denshi Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fukuda Denshi Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Fukuda Denshi Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fukuda Denshi Co (TSE:6960) has a EBITDA Margin % of 0.53% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Fukuda Denshi Co and its competitors. This is 98% below median its historical median of 22.43. Over the past decade, Fukuda Denshi Co's EBITDA Margin % has ranged from 15.75 to 27.91. According to the industry distribution chart, Fukuda Denshi Co ranks #96 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 11.8%.
Is Fukuda Denshi Co's EBITDA Margin % too high?
Fukuda Denshi Co's current EBITDA Margin % of 0.53% is 98% below median its 10-year median of 22.43. Over the past 10 years, this metric has ranged from a low of 15.75 to a high of 27.91. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Fukuda Denshi Co's value of 0.53% is 92.9% below this industry median. Based on the distribution chart, Fukuda Denshi Co ranks #96 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Fukuda Denshi Co has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fukuda Denshi Co's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Fukuda Denshi Co ranks #96 out of 816 companies for EBITDA Margin %. This places Fukuda Denshi Co in the top 12% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.48. Fukuda Denshi Co's value of 0.53% is 92.9% below this benchmark. Historically, Fukuda Denshi Co's own EBITDA Margin % has ranged from 15.75 to 27.91 over the past decade. While the company's 10-year median is 22.43 vs. the industry median of 7.48, Fukuda Denshi Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fukuda Denshi Co's current EBITDA Margin % of 0.53% is 92.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Fukuda Denshi Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fukuda Denshi Co's current EBITDA Margin % is 0.53%, which is 98% below median its own 10-year median of 22.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fukuda Denshi Co stock overvalued right now?
Based on GuruFocus' analysis, Fukuda Denshi Co (TSE:6960) is currently considered Significantly Overvalued. The stock's GF Value™ is 円7,323.71, compared to a current price of 円10,860.00 — trading 48.3% above its estimated fair value. The current EBITDA Margin % is 0.53%, which is 98% below median its 10-year median of 22.43 and 92.9% below the Medical Devices & Instruments industry median of 7.48. Fukuda Denshi Co's overall GF Score™ is 81/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Fukuda Denshi Co (TSE:6960), the current EBITDA Margin % is 0.53% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fukuda Denshi Co (TSE:6960) Overvalued in 2026?
Based on GuruFocus' analysis, Fukuda Denshi Co stock appears to be overvalued.
The current stock price of 円10,860.00 is trading 48.3% above its estimated GF Value™ of 円7,323.71.
GuruFocus considers Fukuda Denshi Co to be Significantly Overvalued.
Key valuation signals for TSE:6960:
EBITDA Margin %: 0.53% (98% below median its 10-year median of 22.43)
GF Value™: 円7,323.71 vs. price of 円10,860.00 (48.3% above fair value)
Industry Position: 92.9% below the Medical Devices & Instruments median (#96 of 816)
No single metric tells the full story. See the TSE:6960 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.
81GF Score
Get the complete analysis for TSE:6960
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6960 has been successfully added to your 
